Subgroup outcomes from RAISE: A randomized, Phase 3 trial of zilucoplan in generalized myasthenia gravis

Weiss, MD; Bresch, S; Freimer, M; Hewamadduma, C; Juntas-Morales, R; Leite, MI; Maniaol, A; Masuda, M; Sivakumar, K; Zajda, M; Boroojerdi, B; Duda, PW; De La Borderie, G; Howard, JF

NEUROLOGY, 2023; 100 (17):